US 10106581
Cyclic peptidomimetic compounds as immunomodulators
granted A61KA61K31/38A61K31/395
Quick answer
US patent 10106581 (Cyclic peptidomimetic compounds as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/38, A61K31/395, A61K38/00, A61P